Compare use cases

Drop two or three slugs into the URL — for example ?slugs=demo-mia-breast-screening,demo-idx-dr-retinopathy — or pick from the validated catalogue below.

Pick from validated:

AI imaging triage for the acute stroke pathway AI second reader for breast cancer screening Autonomous diabetic retinopathy screening in primary care Pre-operative risk-stratification model for major surgery Self-referral assistant for NHS Talking Therapies Type-2 diabetes long-term outcome predictor

Clear selection

	AI second reader for breast cancer screening United Kingdom	Type-2 diabetes long-term outcome predictor Netherlands	Self-referral assistant for NHS Talking Therapies United Kingdom
Trust badge	Validated	Validated	Validated
Evidence strength	Emerging evidence	Robust evidence	Developing evidence
Pipeline stage	Validated	Validated	Validated
Intended use	Acts as an independent second reader of screening mammograms to support the double-reading workflow and reduce reader workload without lowering cancer detection.	Estimates 5-year risk of major diabetes-related complications (cardiovascular, renal, retinal) from longitudinal primary-care records to support care-plan intensification.	Supports patient self-referral by collecting clinical information conversationally and routing referrals, reducing administrative wait time.
Specialty	Radiology	Endocrinology	Psychiatry
Autonomy	Informs a human (advisory)	Informs a human (advisory)	Human in the loop (human acts)
Deployment	Active deployment	Active deployment	Active deployment
EU AI Act tier	High-risk	High-risk	Limited risk
EU MDR class	Class IIb	Not a device	Not a device
CE marking	CE marked	Not required	Not required
NICE ESF tier	Tier C — treat / diagnose / calculate risk	Tier C — treat / diagnose / calculate risk	Tier B — inform / monitor
Headline metric	Sensitivity: 0.91	AUC / AUROC: 0.82	Accuracy: 0.93
Subgroup assessed	Yes	Yes	Yes